CompletedNCT02141113

Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).

This study evaluated the safety and effectiveness of Guanfacine Hydrochloride for people with ADHD.

Medication studyAges 18–65United States

The study in practice

Understand this study

This study evaluated the safety and effectiveness of Guanfacine Hydrochloride for people with ADHD.

Listed age limits: 18 years to 65 years.

Listed locations: Rochester Hills, United StatesSee all locations and recruitment
Activities: Medication described in the protocol · Placebo comparator
Compensation: Payment and expense reimbursement have not been verified.

Study clarity

Study start dateNovember 2012

Recruitment status: Completed
Enrollment listed in the registry: 26
Sponsor: Rochester Center for Behavioral Medicine
Sponsor type: Pharmaceutical company
Study type: Drug
Intervention type: Medication / drug, OTHER
Study phase: Phase 4
Locations: United States
Age range: From 18 Years to 65 Years
Official registry ID: NCT02141113
Official title: Show the full official title
Double-Blind, Randomized, Placebo-Controlled, Single- Center, Dose Optimization Study Evaluating Efficacy and Safety of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults Aged 18-65 Years With a Diagnosis of ADHD

Completed

Rochester Hills

FAQ

What did researchers investigate?

This study evaluated the safety and effectiveness of Guanfacine Hydrochloride for people with ADHD.

Who is behind this study?

The study sponsor is Rochester Center for Behavioral Medicine, a pharmaceutical company.

Did this study involve medication?

Yes. The study involved medication, including Guanfacine Hydrochloride.

Who was this study for?

Listed age limits: 18 years to 65 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.